Outcomes of patients with cancer infected with SARS-CoV-2: results from the Ion Chiricuţă Oncology Institute series

Rosner, 2010 Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7 Dai, 2020, Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak, Cancer Discov, 10, 783, 10.1158/2159-8290.CD-20-0422 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Guan, 2020, Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis, Eur Respir J, 55, 200547, 10.1183/13993003.00547-2020 Onder, 2020, Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy, JAMA, 323, 1775 Barlesi, 2020, Abstract CT403: outcome of cancer patients infected with COVID-19, including toxicity of cancer treatments, Cancer Res, 80, CT403, 10.1158/1538-7445.AM2020-CT403 Zhang, 2020, Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China, Ann Oncol, 31, 894, 10.1016/j.annonc.2020.03.296 Wang, 2020, Risk of COVID-19 for patients with cancer, Lancet Oncol, 21, e181, 10.1016/S1470-2045(20)30149-2 Garassino, 2020, COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study, Lancet Oncol, 21, 914, 10.1016/S1470-2045(20)30314-4 Horby, 2021, Dexamethasone in hospitalized patients with Covid-19, N Engl J Med, 384, 693, 10.1056/NEJMoa2021436 Mahase, 2020, Covid-19: low dose steroid cuts death in ventilated patients by one third, trial finds, BMJ, 369, m2422, 10.1136/bmj.m2422 Beigel, 2020, Remdesivir for the treatment of Covid-19 - final report, N Engl J Med, 383, 1813, 10.1056/NEJMoa2007764 Goldman, 2020, Remdesivir for 5 or 10 days in patients with severe Covid-19, N Engl J Med, 383, 1827, 10.1056/NEJMoa2015301 Guaraldi, 2020, Tocilizumab in patients with severe COVID-19: a retrospective cohort study, Lancet Rheumatol, 2, e474, 10.1016/S2665-9913(20)30173-9 Wang, 2020, Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial, Lancet, 395, 1569, 10.1016/S0140-6736(20)31022-9